23 C
Vientiane
Monday, February 24, 2025
spot_img

Cision PR Newswire

Tencent Cloud Supports Streaming Platform Begin to Boost its Services for Global Audience

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global technology company Tencent, today announced its strategic partnership with Z2C Limited backed Begin, a UAE-based SVOD platform focusing on the Southwest Asian region, to enhance its streaming services for global audience. The partnership agreement was...

Luzerne’s Craftsmanship Helps Dehua Ceramic Trade Association (China) Secure Guinness World Records Title for Largest Porcelain Car Sculpture (supported)

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Luzerne Pte Ltd is proud to announce its crucial role in helping the Dehua Ceramic Trade Association (China)...

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG, Jan. 13, 2025 /PRNewswire/ -- Gianna Lullume, an innovative brand committed to improving infant sleep and promoting family well-being, is proud to...

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc....

Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation

SHENZHEN, China, Jan. 13, 2025 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing,...

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components Innovative technologies presented through a 'User-Centric storytelling' approach elicit strong acclaim, inquiries from...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...